Novartis temporarily paused eight clinical trials of its experimental CAR-T therapy in late August after three patients died from a severe immune response, The Wall Street Journal reported Sept. 1. The Switzerland-based drugmaker was testing the treatment — called rap-cel…
Pharmacy
Louisiana Attorney General Liz Murrill has filed a lawsuit against Express Scripts and its affiliate Ascent Health Services, alleging the companies manipulated Louisiana’s prescription drug market. The state alleges Express Scripts and its partners restricted competition, manipulated pharmacy reimbursement rates,…
The 340B Drug Pricing Program remains an active legal battleground, with drugmakers and covered entities fighting in courts nationwide over contract pharmacy access, patient eligibility and reimbursement practices. Here are five updates from the last two weeks that hospital and…
Columbus, Ohio-based Mount Carmel Health System has named Georgann Mazzoli, PharmD, regional chief pharmacy officer. Dr. Mazzoli stepped into the role in August after more than 15 years with Mount Carmel, according to an Aug. 30 LinkedIn post. She most…
President Donald Trump reached agreements with nine pharmaceutical manufacturers to lower prescription drug prices in the U.S. Here are seven things to know: 1. The agreements bring the total number of pharmaceutical manufacturers with “most-favored-nation” deals to 26, covering 89%…
Advertisement
Illinois pharmacies will be able to electronically transfer more prescriptions from one location to another under a state law that takes effect Jan. 1. The change is intended to allow a pharmacy that cannot fill a prescription to transfer it…
The FDA has approved Mimrylo (rusfertide) to treat adults with polycythemia vera whose disease has not been adequately controlled with existing therapies. Mimrylo is the first approved treatment for polycythemia vera that mimics hepcidin, a hormone that regulates iron in…
The FDA has approved Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal heart attack or nonfatal stroke, in adults with type 2 diabetes who are at high risk for these events. The approval…
Walmart has agreed to pay $50 million to resolve allegations that its pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act. The Justice Department alleged that Walmart’s compliance team…
Milwaukee-based Froedtert Memorial Lutheran Hospital sued CVS Health Aug. 20 alleging the company and its subsidiaries diverted about $18 million in 340B drug pricing savings from the hospital between 2020 and 2025. The complaint, filed in U.S. District Court for…